<DOC>
	<DOCNO>NCT02831738</DOCNO>
	<brief_summary>Primary outcome measure : Changes plasma glucose concentration 3 hour postprandial visit administration polydextrose ( 12g ) compare 0 mg placebo . Secondary outcome measure : Changes gastrointestinal tolerance acute bowel change 3 day follow treatment administration .</brief_summary>
	<brief_title>Fiber Effects Glycemic Index</brief_title>
	<detailed_description>This study randomize , 2-arm , single-blinded , control , cross-over trial design focus determine health benefit associate Polydextrose intake . A planned sample size 20 enrol study . This study require one initial screen visit 2 weekly study visit . This study take approximately 2-3 week per subject complete 3-hr study visit two different occasion . The initial screening visit provide subject inform consent document determine subject eligibility anthropometric measurement , vital sign , fast blood glucose test ( finger prick ) , completion survey relate general eating , health , exercise habit . If willing eligible participate , subject invite participate study 2 study visit . Subjects instruct maintain usual diet pattern physical activity throughout study duration . A dinner meal provide day study visit control second meal effect food beverage intake night study visit . Subject arrive center fast state least 10 hour , well hydrate rest . Each study visit require blood draw throughout visit . After evaluation subject 's health status ( via anthropometric , vital sign blood glucose measurement in-person interview ) , Licensed health Care Professional place catheter subject 's arm purpose multiple blood sample collection take initial blood draw fast state . Subjects randomize receive placebo test food base randomize treatment sequence 2 study visit two different occasion . The sequence receive test food visit randomly assign one sequence . Each study visit involve blood sample collection time point 0 ( fast ) , 0.5 , 1 , 2 , 3 hour ( h ) assessment change plasma glucose concentration .</detailed_description>
	<criteria>*Subject male female age 20 55 year age Subject BMI 20.0 32.0 kg/m2 screen visit Fasting blood sugar le 126 mg/dL Subject willing maintain stable body weight follow his/her regular diet physical activity pattern throughout study period . Subject willing refrain vigorous physical activity consumption alcoholic and/or caffeinated beverage 24 h prior test day Subject smoke abstain smoke least 2 year No clinical evidence cardiovascular , metabolic , respiratory , renal , gastrointestinal hepatic disease Not take medication dietary supplement would interfere outcomes study . Subject typically consume low fiber diet correlate average fiber intake typical western diet . *Subject currently smoke smoke within past 2 year Men woman know suspected food intolerance , allergy hypersensitivity study material closely related compound Men woman know have/diagnosed diabetes mellitus Men woman fast blood glucose concentration â‰¥126 mg/dL Average blood pressure &gt; 140 mmHg/90 mmHg screen visit Men woman document vascular disease , e.g. , heart failure , myocardial infarction , stroke , angina , related surgery Men woman cancer nonmelanoma skin cancer previous 5 year Men woman take medication dietary supplement may interfere outcome study . Subjects may choose go dietary supplement ( require 30 day washout )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Fiber</keyword>
	<keyword>Polydextrose</keyword>
	<keyword>Glycemic Index</keyword>
</DOC>